Gelatinase activity of matrix metalloproteinases in the cerebrospinal fluid of various patient populations.
We have studied the enzymatic gelatinolytic activity of matrix metalloproteinases (MMPs) present in cerebrospinal fluid (CSF) of samples obtained from 67 individuals, twenty-one nonneurological patients (considered controls) and 46 subjects with various neurological disorders e.g., vascular lesions, demyelination, inflammatory, degenerative and prion diseases. Biochemical characterization of MMPs, a family of neutral proteolytic enzymes involved in extracellular matrix modeling, included determination of substrate specificity and Ca+2 dependency, as well as the effects of protease inactivators, carboxylic and His (histidine) residue modifiers, and antibiotics. Whereas all CSF samples expressed MMP-2 (gelatinase A) activity, it corresponded in most cases (normal and pathological samples) to its latent form (proenzyme; pMMP-2). In general, inflammatory neurological diseases (especially meningitis and neurocisticercosis) were associated with the presence of a second enzyme, MMP-9 (or gelatinase B). Whereas MMP-9 was found in the CSF of every tropical spastic paraparesis patient studied, its presence in samples from individuals with vascular lesions was uncommon. Patients blood-brain barrier damage was ascertained by determining total CSF protein content using both, the conventional polyacrylamide gel electrophoresis procedure under denaturing conditions and capillary zone electrophoresis.
Valenzuela
M A
MA
Department of Biochemistry and Molecular Biology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago. mavalenz@abello.dic.uchile.cl
Cartier
L
L
Collados
L
L
Kettlun
A M
AM
Araya
F
F
Concha
C
C
Flores
L
L
Wolf
M E
ME
Mosnaim
A D
AD
D004789:Enzyme Activation; D018093:Gelatinases / Q000134:cerebrospinal fluid*; D006801:Humans; D020782:Matrix Metalloproteinases / Q000134:cerebrospinal fluid*; D009422:Nervous System Diseases / Q000134:cerebrospinal fluid / Q000201:enzymology*; D010662:Phenylmercuric Acetate / Q000031:analogs & derivatives / Q000737:chemistry; D013379:Substrate Specificity
C010024:4-aminophenylmercuriacetate; D018093:Gelatinases; D020782:Matrix Metalloproteinases; D010662:Phenylmercuric Acetate